Healthcare in Autoimmune Eye Conditions MHRA approves teprotumumab as the first UK treatment for adults with moderate to severe Thyroid Eye Disease (TED) admin October 2, 2025 The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 7 May 2025, approved...Read More Body Healthcare MHRA announces two new UK Approved Bodies to certify medical devices admin March 1, 2024 LNE-GMED UK and Scarlet NB UK join the seven current UK Approved Bodies, increasing...Read More
Body Healthcare MHRA announces two new UK Approved Bodies to certify medical devices admin March 1, 2024 LNE-GMED UK and Scarlet NB UK join the seven current UK Approved Bodies, increasing...Read More
